PHARMO Institute, part of Lumanity

Don't miss the poster currently on display at the International Society for Pharmacoepidemiology annual meeting, Migration background and HbA1c Checks and Balances: a large routine care data study in the Netherlands, and be sure to catch Jetty Overbeek to discuss it in further detail. #ICPE24 #epidemiology #pharmacoepidemiology #routinecare #HbA1c #ISPEAnnual2024

🌟Exciting times at the 2024 International Society for Pharmacoepidemiology Annual Meeting! 🌟   We had a fantastic first day yesterday diving into insightful sessions and networking with our research partners and clients. We're eager to see what the second day has in store for us!   A special shoutout to three standout sessions that we liked particularly and recommend exploring further: - Evaluation of Data Quality in Multi-Database Pharmacoepidemiologic Studies: Current Practices and Future Trends - Specification of Time Zero in Causal Inference Studies Using Real-World Data: Challenges and Solutions - Prevalent New User Designs: State of the Science and Considerations for Complex Clinical Scenarios   Huge thanks to the speakers and organizers for such a great event. Let’s keep the learning and collaboration going!   #ICPE24 #ICPE2024 #epidemiology #pharmacoepidemiology #research #learning #innovation #ISPEAnnual2024

Don't miss the poster currently on display at the International Society for Pharmacoepidemiology annual meeting, Characteristics of Patients with ATTR Amyloidosis and Methodological Approaches for Establishing Clinical Subtype in the Netherlands. #ICPE24 #epidemiology #pharmacoepidemiology #amyloidosis #ATTR #ISPEAnnual2024

If you're at the International Society for Pharmacoepidemiology annual meeting, be sure to check out our posters today, including the following two: - Identifying and profiling patients with heart failure in a population-based cohort through linkage of primary and secondary care data - Factor XA Inhibitor-related major bleeding events in the Netherlands #ICPE24 #epidemiology #pharmacoepidemiology #heartfailure #fxai #caredata #ISPEAnnual2024

If you're in Berlin at the International Society for Pharmacoepidemiology annual meeting, be sure to stop by exhibit booth 901, chat with our experts, and learn about some of our latest research. For the full list of our presentations at ICPE this week, visit https://buff.ly/3AP5bOf #ICPE24 #epidemiology #pharmacoepidemiology #healthcaredata #ISPEAnnual2024

Wij zijn op zoek naar een nieuwe Research Manager-Real World Evidence in London, England (#hiring). Solliciteer vandaag nog of deel deze bijdrage met uw netwerk.

The International Society for Pharmacoepidemiology annual meeting is underway in Berlin! Don't miss all of our oral presentations and posters, including: Oral Presentations: - Target Trial Emulation with Real World Evidence: Regulatory Grade Pharmacoepidemiology in the SIGMA consortium - GP consultation for menstrual disorders after COVID-19 vaccination – a self-controlled cohort study based on healthcare data from the Netherlands - Impact of data source diversity on the distribution of key variables in cohorts of pregnancies extracted with the ConcePTION algorithm leveraging on a random forest imputation model - Unravelling Sex Disparities in Statin Dose Titration Patterns in Primary Care Posters: - Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe - Safety of the Janssen COVID-19 vaccine (JCOVDEN) using VAC4EU European Healthcare Data: Methods and Results of the Second Study Feasibility Assessment - Migration background and HbA1c Checks and Balances: a large routine care data study in the Netherlands - Readiness of electronic healthcare record data sources for rapid evaluation of safety signals of SARS-CoV-2 Vaccines in Europe: results from the Covid-19 Vaccine Monitoring project - Challenges of multi-country post-authorisation safety studies for surveillance of new medical products - Oral antihypertensives in hypertensive pregnancy and the association with fetal growth: a population-based cohort study - Characteristics of Patients with ATTR Amyloidosis and Methodological Approaches for Establishing Clinical Subtype in the Netherlands - Rates of SARS-CoV-2 breakthrough infection or severe COVID-19 and associated risk factors after primary and booster vaccination against COVID-19 in the Netherlands - Identifying and profiling patients with heart failure in a population-based cohort through linkage of primary and secondary care data - Factor XA Inhibitor-related major bleeding events in the Netherlands - Use of SGLT2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease – a Multi-Country Report from the FOUNTAIN Platform - Exploring sources of statistical heterogeneity in a multi-database observational study: results from a case study using EXACOS-CV Connect with our staff while in Berlin, including Eline Houben, Jetty Overbeek, Josine Kuiper, Naomi Boxall, Eleonora Iob, PhD, and Nikita Jeswani, and don't forget to stop by exhibit booth 901! Learn more about the conference and the program agenda at https://buff.ly/4fRJHAt #ICPE2024 #pharmacoepidemiology #epidemiology #RWE #RWD #SafetyStudies #Amyloidosis #SIGMAConsortium #ISPEAnnual2024

We're proud to be a Gold sponsor and exhibitor at the annual International Society for Pharmacoepidemiology meeting this week! Be sure to connect with our staff on site, including Eline Houben, Jetty Overbeek, Josine Kuiper, Naomi Boxall, Eleonora Iob, PhD, and Nikita Jeswani, and don't miss all of our presentations, including 1 workshop, two oral presentations, and 10 posters! Reach out to our on-site staff or stop by booth 901 during the conference. See you soon! #ICPE24 #epidemiology #pharmacoepidemiology #RWE #RWD #healthcaredata #ISPEAnnual2024

We're looking forward to the International Society for Pharmacoepidemiology (ICPE) annual meeting and are excited to connecting with everyone there. We invite you to visit booth 901, check out our presentations during the conference, and connect with our staff to speak about some of our indication areas of expertise, including #Oncology, #Hematology, #Diabetes, #Cardiovascular, #CNS, #Respiratory, #Nephrology, and #MaternalCare. Schedule time to meet with us during the conference by emailing [email protected] #ICPE24 #epidemiology #pharmacoepidemiology #RWD #RWE

Looking forward to the upcoming Royal Statistical Society (RSS) International Conference 2024. Don't miss our rapid-fire talk, Enhancing the identification and profiling of patients with heart failure in a population-based cohort through linkage of primary and secondary care data, on September 4, 15:10-15:50. Learn more at https://lnkd.in/e6mUTj5C #RSS2024 #heartfailure #statistics #caredata #patientprofiling